Contact
searchSearch
HMP Global

ACTRIMS

Conference Coverage
Study Links MS-Related Fatigue to Disability Status and Lower Quality of Life
03/13/2025
Grace Taylor, MS, MA
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is...
03/13/2025
First Report Managed Care
Conference Coverage
Study Examines the Effects of MS Treatment on Mobility and Emergency Care
03/13/2025
Juliet Gallagher
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study...
03/13/2025
First Report Managed Care
Conference Coverage
Ozanimod Shows Promise in Preserving Brain Volume in Patients With Early Relapsing MS
03/04/2025
Hannah Musick
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in...
03/04/2025
First Report Managed Care
Conference Coverage
Immunomodulatory Effects of Modified Atkins Diet in Patients With Multiple Sclerosis
03/04/2025
Hannah Musick
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a...
03/04/2025
First Report Managed Care
Conference Coverage
MSDA Test Helps Guide Multiple Sclerosis Treatment Decisions, Study Finds
02/28/2025
Grace Taylor, MS, MA
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test...
02/28/2025
First Report Managed Care
Conference Coverage
Study Finds No Treatment Disparities in MS Care Between Medicaid and Private Insurance
02/28/2025
Grace Taylor, MS, MA
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025...
02/28/2025
First Report Managed Care
Conference Coverage
The Clinical and Economic Burden of Primary Progressive Multiple Sclerosis
02/27/2025
Grace Taylor, MS, MA
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the...
02/27/2025
First Report Managed Care
Conference Coverage
Leveraging AI for Multiple Sclerosis Diagnosis
02/27/2025
Grace Taylor, MS, MA
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s...
02/27/2025
First Report Managed Care

Conference Coverage
Study Links MS-Related Fatigue to Disability Status and Lower Quality of Life
03/13/2025
Grace Taylor, MS, MA
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is...
03/13/2025
First Report Managed Care
Conference Coverage
Study Examines the Effects of MS Treatment on Mobility and Emergency Care
03/13/2025
Juliet Gallagher
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study...
03/13/2025
First Report Managed Care
Conference Coverage
Ozanimod Shows Promise in Preserving Brain Volume in Patients With Early Relapsing MS
03/04/2025
Hannah Musick
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in...
03/04/2025
First Report Managed Care
Conference Coverage
Immunomodulatory Effects of Modified Atkins Diet in Patients With Multiple Sclerosis
03/04/2025
Hannah Musick
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a...
03/04/2025
First Report Managed Care
Conference Coverage
MSDA Test Helps Guide Multiple Sclerosis Treatment Decisions, Study Finds
02/28/2025
Grace Taylor, MS, MA
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test...
02/28/2025
First Report Managed Care
Conference Coverage
Study Finds No Treatment Disparities in MS Care Between Medicaid and Private Insurance
02/28/2025
Grace Taylor, MS, MA
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025 ACTRIMS Forum shows that individuals with Medicaid receive similar high-efficacy treatment for multiple sclerosis as those with private insurance, supporting Medicaid’s role in promoting health equity.
A study presented at the 2025...
02/28/2025
First Report Managed Care
Conference Coverage
The Clinical and Economic Burden of Primary Progressive Multiple Sclerosis
02/27/2025
Grace Taylor, MS, MA
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the significant health care challenges and costs associated with primary progressive multiple sclerosis (PPMS).
New research highlights the...
02/27/2025
First Report Managed Care
Conference Coverage
Leveraging AI for Multiple Sclerosis Diagnosis
02/27/2025
Grace Taylor, MS, MA
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s ability to classify multiple sclerosis diagnosis from clinical notes, finding promising but imperfect results with 74% overall accuracy.
Researchers tested GPT-4’s...
02/27/2025
First Report Managed Care
Conference Coverage
Unlocking the Power of Mortality Data in Real-World Evidence: Overcoming Barriers and Driving Innovation
06/12/2026
Presenters at ISPOR 2026 demonstrated how integrating mortality data from multiple sources can substantially improve death ascertainment and strengthen the validity of real-world evidence for research and decision-making.
Presenters at ISPOR 2026 demonstrated how integrating mortality data from multiple sources can substantially improve death ascertainment and strengthen the validity of real-world evidence for research and decision-making.
Presenters at ISPOR 2026...
06/12/2026
First Report Managed Care
Conference Coverage
The Enduring Challenge of Medical Device Identification: Is Artificial Intelligence Abstraction Ready for Broad Use and Acceptance?
06/12/2026
Experts at ISPOR 2026 explored how generative AI may overcome longstanding challenges in medical device identification, enabling more accurate and scalable real-world evidence generation from unstructured clinical data.
Experts at ISPOR 2026 explored how generative AI may overcome longstanding challenges in medical device identification, enabling more accurate and scalable real-world evidence generation from unstructured clinical data.
Experts at ISPOR 2026 explored...
06/12/2026
First Report Managed Care
Conference Coverage
Closing the Clinical Impact Evidence Gap: Practical RWE Strategies for Medical Devices and Diagnostics Using Registries, Research Partners, and Regulatory Data
06/12/2026
Experts at ISPOR 2026 highlighted how registries, linked data sources, and research collaborations can generate real-world evidence that bridges clinical evidence gaps for medical devices and diagnostics when traditional trials are not...
Experts at ISPOR 2026 highlighted how registries, linked data sources, and research collaborations can generate real-world evidence that bridges clinical evidence gaps for medical devices and diagnostics when traditional trials are not...
Experts at ISPOR 2026...
06/12/2026
First Report Managed Care
Conference Coverage
Listening at Scale: AI-Powered Insights into Systemic Lupus Erythematosus Patient Needs From Social Media
06/11/2026
Mitch DeKoven
Researchers found that AI-powered analysis of thousands of Reddit posts can identify unmet needs, symptom burdens, and care challenges among patients with systemic lupus erythematosus, highlighting the potential of social media listening to...
Researchers found that AI-powered analysis of thousands of Reddit posts can identify unmet needs, symptom burdens, and care challenges among patients with systemic lupus erythematosus, highlighting the potential of social media listening to...
Researchers found that...
06/11/2026
First Report Managed Care
Conference Coverage
From Debate to Dialogue: Building Consensus on Prior Authorization Reform
06/11/2026
Mitch DeKoven
The growing use of prior authorization continues to create challenges for patients and providers, but experts at ISPOR 2026 outlined policy reforms and emerging AI-driven solutions that could improve transparency, efficiency, and access to...
The growing use of prior authorization continues to create challenges for patients and providers, but experts at ISPOR 2026 outlined policy reforms and emerging AI-driven solutions that could improve transparency, efficiency, and access to...
The growing use of prior...
06/11/2026
First Report Managed Care
Conference Coverage
The Business of Evidence: HEOR for C-Suite Decision Making
06/11/2026
Mitch DeKoven
A forum at ISPOR 2026 highlighted how HEOR leaders can drive organizational growth by translating complex value evidence into strategic insights that resonate with C-suite priorities.
A forum at ISPOR 2026 highlighted how HEOR leaders can drive organizational growth by translating complex value evidence into strategic insights that resonate with C-suite priorities.
A forum at ISPOR 2026...
06/11/2026
First Report Managed Care
Conference Coverage
Portable Ultra-Low Field MRI Shows Promise in Multiple Sclerosis Monitoring
05/28/2026
Hannah Musick
In a study presented at CMSC 2026, portable ultra-low field magnetic resonance imaging (MRI) showed improved image quality and lesion detection after software upgrades, highlighting its potential to expand multiple sclerosis imaging access in...
In a study presented at CMSC 2026, portable ultra-low field magnetic resonance imaging (MRI) showed improved image quality and lesion detection after software upgrades, highlighting its potential to expand multiple sclerosis imaging access in...
In a study presented at CMSC...
05/28/2026
First Report Managed Care
Conference Coverage
African American Patients With Multiple Sclerosis Show Greater Neurodegeneration
05/28/2026
Hannah Musick
New research found that African American patients with multiple sclerosis (MS) experienced greater neurodegeneration, worse cognitive and motor performance, and accelerated brain aging compared with White patients despite having a shorter...
New research found that African American patients with multiple sclerosis (MS) experienced greater neurodegeneration, worse cognitive and motor performance, and accelerated brain aging compared with White patients despite having a shorter...
New research found that African...
05/28/2026
First Report Managed Care
Conference Coverage
Patient-Centered AI Monitoring Platform Shows Promise in Multiple Sclerosis Care
05/28/2026
Grace Taylor, MS, MA
A patient-centered remote therapeutic monitoring platform combining tele-exercise, wearable data, and artificial intelligence (AI)-enabled decision support improved mobility outcomes and clinician usability in people with multiple sclerosis,...
A patient-centered remote therapeutic monitoring platform combining tele-exercise, wearable data, and artificial intelligence (AI)-enabled decision support improved mobility outcomes and clinician usability in people with multiple sclerosis,...
A patient-centered remote...
05/28/2026
First Report Managed Care
Conference Coverage
Phase 3 FENtrepid Study Tests Fenebrutinib for Progressive MS Disability Progression
05/27/2026
Grace Taylor, MS, MA
The phase 3 FENtrepid trial compared fenebrutinib with ocrelizumab to determine whether Bruton tyrosine kinase inhibition can better slow disability progression in primary progressive multiple sclerosis (MS).
The phase 3 FENtrepid trial compared fenebrutinib with ocrelizumab to determine whether Bruton tyrosine kinase inhibition can better slow disability progression in primary progressive multiple sclerosis (MS).
The phase 3 FENtrepid trial...
05/27/2026
First Report Managed Care

What's New?

Conference Coverage
Study Links MS-Related Fatigue to Disability Status and Lower Quality of Life
03/13/2025
Grace Taylor, MS, MA
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is strongly linked to lower quality of life, particularly in those with higher disability scores, and decreased work capacity, according to recent research.
Fatigue in multiple sclerosis is...
03/13/2025
First Report Managed Care
Conference Coverage
Study Examines the Effects of MS Treatment on Mobility and Emergency Care
03/13/2025
Juliet Gallagher
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study presented at the 2025 ACTRIMS Forum challenges conventional assumptions regarding disease-modifying therapies (DMTs) in multiple sclerosis (MS). While DMTs are designed to reduce relapse rates and MRI activity,...
A retrospective cohort study...
03/13/2025
First Report Managed Care
Conference Coverage
Ozanimod Shows Promise in Preserving Brain Volume in Patients With Early Relapsing MS
03/04/2025
Hannah Musick
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in patients with early relapsing multiple sclerosis (MS) showed promising results in preserving brain volume over 1 year, potentially slowing down the accelerated brain volume loss seen in patients with MS.
Treatment with ozanimod in...
03/04/2025
First Report Managed Care
Conference Coverage
Immunomodulatory Effects of Modified Atkins Diet in Patients With Multiple Sclerosis
03/04/2025
Hannah Musick
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a modified Atkins diet in patients with multiple sclerosis reveals significant changes in immune cell metabolism and anti-inflammatory responses, suggesting the potential for dietary interventions in multiple...
A study on the effects of a...
03/04/2025
First Report Managed Care
Conference Coverage
MSDA Test Helps Guide Multiple Sclerosis Treatment Decisions, Study Finds
02/28/2025
Grace Taylor, MS, MA
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test helps guide treatment decisions in multiple sclerosis based on objective changes in treatment plan and clinician reported impact, according to a study presented at the 2025 ACTRIMS Forum.
The MS Disease Activity test...
02/28/2025
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use